These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23428099)

  • 1. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbicides to prevent HIV transmission: overcoming obstacles to chemical barrier protection.
    Dhawan D; Mayer KH
    J Infect Dis; 2006 Jan; 193(1):36-44. PubMed ID: 16323129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbicides: putting women in control.
    Forbes A
    WORLD; 1998 Sep; (89):4-5. PubMed ID: 11365770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future strategies in microbicide development.
    Rosenberg ZF; Devlin B
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):503-13. PubMed ID: 22406260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L; Liebenberg L; Barnabas S; Passmore JA
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):441-9. PubMed ID: 22429786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies.
    Friend DR; Doncel GF
    Antiviral Res; 2010 Dec; 88 Suppl 1():S47-54. PubMed ID: 21109068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The acceptability on vaginal microbicides to prevent human immunodeficiency virus/sexually transmitted diseases].
    Han L; Wu ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):196-8. PubMed ID: 19565887
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical microbicides--what's new?
    Karim QA; Baxter C; Karim SA
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2():S144-9. PubMed ID: 23764627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's interest in vaginal microbicides.
    Darroch JE; Frost JJ
    Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the development of vaginal microbicides. International Working Group on Vaginal Microbicides.
    AIDS; 1996 Jul; 10(8):1-6. PubMed ID: 8828760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterosexual anal intercourse has the potential to cause a significant loss of power in vaginal microbicide effectiveness studies.
    McGowan I; Taylor DJ
    Sex Transm Dis; 2010 Jun; 37(6):361-4. PubMed ID: 20514687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.
    Karim QA; Baxter C; Karim SA
    BJOG; 2014 Oct; 121 Suppl 5(0 5):53-61. PubMed ID: 25335841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting sexual transmission of HIV-1 infection.
    Shattock RJ; Moore JP
    Nat Rev Microbiol; 2003 Oct; 1(1):25-34. PubMed ID: 15040177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbicides for preventing sexually transmitted infections: Current status and strategies for preclinical evaluation of new candidates].
    Fernández Romero JA; Gil PI; Ré V; Robbiani M; Paglini G
    Rev Argent Microbiol; 2014; 46(3):256-68. PubMed ID: 25444135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of introducing vaginal microbicides in India.
    Joshi S; Kulkarni V; Paranjape R; Chandhiok N
    Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.